Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Tari A. King, MD, FACS

Surgical Oncology

Make an Appointment
Watch Video

Tari A. King, MD, FACS americas top doctors


  • Chief, Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital
  • Vice Chair for Multidisciplinary Oncology, Department of Surgery, Brigham and Women's Hospital
  • Senior Physician
  • Anne E. Dyson Professor of Surgery in the Field of Women's Cancers, Harvard Medical School


Clinical Interests

  • Inflammatory breast cancer
  • Lobular carcinoma in situ
  • Optimizing local therapy for early-stage breast cancer
  • Surgery for the primary tumor in stage IV breast cancer

Diseases Treated

Contact Information

  • Appointments617-632-2175 (new)
    617-632-3891 (follow-up)
  • Office Phone Number617-632-3891
  • Fax617-632-2495


Dr. Tari A. King is the Anne E. Dyson Professor of Surgery at Harvard Medical School, the chief of the Division of Breast Surgery and the vice chair of multidisciplinary oncology in the Department of Surgery at Brigham and Women's Hospital, and the chief of breast surgery at Dana-Farber Brigham Cancer Center. She is also the director of the Breast Cancer Personalized Risk Assessment, Education and Prevention (B-PREP) Program at Brigham and Women's Hospital. Dr. King received her medical degree from University of Colorado Health Sciences Center and completed a general surgery residency at Ochsner Clinic Foundation Hospital (now Ochsner Medical Center) in New Orleans. Dr. King completed both a surgical research fellowship and a breast surgery clinical fellowship at Memorial Sloan Kettering Cancer Center. Her clinical and research efforts focus on improving clinical management strategies for women at high risk of developing breast cancer with a special emphasis on lobular carcinoma in situ and atypical hyperplasia. She also has an interest in the role of surgery in stage IV breast cancer and through the Translational Breast Cancer Research Consortium (TBCRC) she successfully initiated and completed accrual to a multi-center trial addressing this issue. She has received several awards to support her work on high-risk breast lesions, including the Society of Surgical Oncology (SSO) Clinical Investigator Award in Breast Cancer Research (2008), a Career Catalyst Award (2009), an Investigator Initiated Research Award (2012) and a leadership grant from the Susan G. Komen for the Cure Foundation (2016). Most recently she was awarded a BWH Precision Medicine Award (2018-19). Dr. King currently serves on the Steering Committee for the TBCRC, the NCI Breast Oncology Local Disease Task Force and the 2019 AACR Cancer Progress Report. She is also a member of Executive Council and the chair of the Quality Committee for the SSO.

Board Certification:

  • Surgery, 2002


  • Memorial Sloan Kettering Cancer Center, Breast Surgery
  • Memorial Sloan Kettering Cancer Center, Research Fellowship


  • Ochsner Medical Institutions, General Surgery

Medical School:

  • University of Colorado Health Sciences Center


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions